23 results
PRE 14A
SCPH
scPharmaceuticals Inc
12 Apr 24
Preliminary proxy
4:14pm
, Inc., the Board of Trustees of the Maryland Historical Society, Woodhaven Holding Corporation and Paradigm Management Services, LLC. Mr. Hudson also … ). In 2022, Dr. Abraham received the Pioneer Award from the Heart Failure Society of America, given to an innovator in the field of heart failure
424B5
SCPH
scPharmaceuticals Inc
23 Nov 22
Prospectus supplement for primary offering
4:15pm
of $5.40 per share. The warrants are immediately exercisable, and the exercise period will expire 7 years from the date of issuance.
Heart Failure Society … Failure Society of America’s 2022 Annual Scientific Meeting. The first poster described the results of the AT HOME-HF study, a Phase 2, multicenter, pilot
424B5
02s6cq kzityxyjra
21 Nov 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
jwsq0
9 Nov 22
Entered into a secured debt financing agreement for up to $100 million with funds managed by Oaktree
4:07pm
8-K
EX-99.1
t0grj19k euuz94
16 May 22
Continuing to ramp up commercial readiness activities in advance of an anticipated Q4 2022 launch of FUROSCIX®, if approved
7:26am
8-K
tk1kbf xc
10 Sep 21
Heart Failure Society of America Annual Scientific Meeting 2021
8:12am
8-K
EX-99.1
cxag95a
10 Sep 21
Heart Failure Society of America Annual Scientific Meeting 2021
8:12am
8-K
EX-99.1
yym8hpb
11 Aug 21
Announced positive top-line results from the FREEDOM-HF study demonstrating that average 30-day heart failure-related costs
7:07am
8-K
EX-99.1
ksn9dwan389qfhg
16 Nov 20
Results of Operations and Financial Condition
7:31am
8-K
EX-99.1
klx1de n22
13 Aug 20
Provides Business Update
7:05am